首页> 美国政府科技报告 >Epidermal Growth Factor-Like Ligands in Breast Cancer
【24h】

Epidermal Growth Factor-Like Ligands in Breast Cancer

机译:乳腺癌中的表皮生长因子样配体

获取原文

摘要

Cripto-1 (Cr-1) and Amphiregulin (Ar) are two EGF-like growth factors that occur at higher levels than normal in breast cancer cells and tissues. They occur during mammary cell proliferation in normal virgin, pregnant and lactating mouse mammary glands, and in early embryo cells. To test the roles of Cr-1, we infected normal mouse mammary cells with retroviruses over-expressing Cr-1, or an antisense version, in order to inhibit the production of this polypeptide. Cr-1 stimulated proliferation and was inhibitory to differentiation (lactation). Reduction of Cr-1 did not affect differentiation but decreased growth rate and increased apoptosis. Cr-1 overexpression transforms cells but appears not to be tumorigenic. We completely inactivated the Cr-1 genes in order to produce mice that expressed no Cr-1 in mammary glands as well as in all other tissues. To this end, we inactivated Cr-1 in embryo stem (ES) cells by homologous recombination and produced Cr-1 gene-targeted mice. Studies on these Cr-1 (-/-) cells showed that ES cell differentiation to cardiac myocytes was prevented. The 'knockout' animals demonstrate that Cr-1 is essential for axis formation and embryonic development. Cr-1 absence causes aberrant proliferation of mesoderm cells, loss of migratory signals and absence of heart development.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号